United Technologies Corp. (NYSE: UTX) beat revenue and earnings estimates for the third quarter of 2019. Shares were up 1.3% in premarket hours on Tuesday.
Total sales rose 18% year-over-year to $19.5 billion, beating estimates of $19.3 billion. Organic sales grew 5%.
On a GAAP basis, net income fell 7% to $1.1 billion compared to the prior-year quarter while EPS was $1.33, down 14%. Adjusted EPS increased 15% to $2.21, surpassing estimates of $2.03.
During the quarter, Collins Aerospace commercial aftermarket sales were up 78% and up 20% organically. On a pro forma basis, Collins Aerospace commercial aftermarket sales were up 17% including Rockwell Collins.
Pratt & Whitney commercial aftermarket sales rose 6%. Equipment orders at Carrier fell 11% organically. Otis new equipment orders were up 6% at constant currency in the third quarter.
Looking ahead, United expects continued strength at Collins Aerospace, including the integration of Rockwell Collins, and a lower tax rate to more than offset softness at Carrier.
The company remains on track to establish Otis and Carrier as independent companies in the first half of 2020, with the end of the first quarter as its target.
United updated its outlook for FY19 and now expects adjusted EPS of $8.05-8.15 versus the prior range of $7.90 to $8.05. Reported sales is expected to be $76 billion to $76.5 billion versus the previous outlook of $75.5 billion to $77 billion. Organic sales growth is expected to be 4-5%.
Earlier this month, shareholders of United Technologies and Raytheon Company (NYSE: RTN) approved the proposed merger of equals between both companies. The transaction is expected to close in the first half of 2020.
Listen to on-demand earnings calls and hear how management responds to analysts’ questions
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
